The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Uric Acid as a CNS Antioxidant
Open accessAbstract
Oxidative damage is a consistent finding in a number of central nervous system (CNS) disorders. Uric acid (UA) is a potent hydrophilic antioxidant that is modified by diet and drug. Several lines of evidence suggest that plasma UA may modulate outcomes in neurologic disease, but little attention has been paid to CNS levels of UA. Our objective was to test the hypothesis that cerebrospinal fluid (CSF) UA is determined by plasma UA, modified by blood-brain barrier (BBB) integrity and associated with rate of cognitive decline in Alzheimer's disease (AD). Also, since UA and ascorbic acid may act as antioxidants for one another, we also explored a potential interaction between them in the brain. Thirty-two patients with mild to moderate AD (Mini-Mental Status Exam 19 +/- 5) participated in a longitudinal biomarker study for one year involving standardized clinical assessments. CSF and blood were collected at baseline for UA, ascorbic acid, and albumin. Cognitive measures were collected at baseline and again one year later. CSF UA was independent of age, gender, and AD severity. CSF and plasma UA were positively correlated (r=0.669, p=0.001) and BBB impairment was associated with higher CSF levels of UA (p=0.028). Neither plasma nor CSF UA reached significant association with rates of cognitive decline over 1 year. CSF UA and CSF ascorbic acid were positively correlated (r=0.388, p=0.001). The hypothesis that CSF UA is determined by plasma UA and BBB integrity is supported, as is the hypothesis that UA and ascorbic acid are associated in CSF but not plasma. Adequately powered prospective studies would help assess any role for UA in primary and secondary prevention of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · cited 1×
“…evaluation included medical history, physical exam, Mini-Mental Status Exam (MMSE) [31], Clinical Dementia Rating (CDR) [32], Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-Cog) [33], Hachinski ischemia score [34] as a measure of vascular burden, and Geriatric Depression Scale [35].”
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Ascorbate is an outstanding antioxidant in human blood plasma
Frei, B., England, L., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6377 · Cited by 1,870
Self-citationTibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091496 · Cited by 966
Choi, H. K., Liu, S., & Curhan, G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20761 · Cited by 595
Hooper, D. C., Spitsin, S., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudhry, I., & Koprowski, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.675 · Cited by 569
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease
Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 549
Plasma Urate and Risk of Parkinson's Disease
Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm127 · Cited by 390
Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., & Spitsin, S. V. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.691 · Cited by 390
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias
Moroney, J. T., Bagiella, E., Desmond, D. W., Hachinski, V. C., Mölsä, P. K., Gustafson, L., Brun, A., Fischer, P., Erkinjuntti, T., Rosen, W., et al. (1997) · Neurology · doi:10.1212/wnl.49.4.1096 · Cited by 316
Differential compartmentalization of brain ascorbate and glutathione between neurons and glia
Rice, M. E., & Russo-Menna, I. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00347-3 · Cited by 313
Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
Schwarzschild, M. A. (2008) · Archives of Neurology · doi:10.1001/archneur.2008.65.6.nct70003 · Cited by 310
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Blood–brain barrier impairment in Alzheimer disease: Stability and functional significance
Bowman, G. L., Kaye, J. A., Moore, M., Waichunas, D., Carlson, N. E., & Quinn, J. F. (2007) · Neurology · doi:10.1212/01.wnl.0000262031.18018.1a · Cited by 293
Self-citationDecreased plasma antioxidants in patients with Alzheimer's disease
Kim, T.-S., Pae, C.-U., Yoon, S.-J., Jang, W.-Y., Lee, N. J., Kim, J.-J., Lee, S.-J., Lee, C., Paik, I.-H., & Lee, C.-U. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1469 · Cited by 291
The species distribution of xanthine oxidase
Al-Khalidi, U., & Chaglassian, T. (1965) · Biochemical Journal · doi:10.1042/bj0970318 · Cited by 271
Serum urate as an antioxidant for ascorbic acid
Sevanian, A., Davies, K., & Hochstein, P. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1129s · Cited by 261
Free radical metabolite of uric acid.
Maples, K. R., & Mason, R. P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77933-2 · Cited by 227
Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease
Davis, J. W., Grandinetti, A., Waslien, C. J., Ross, G. W., White, L. R., & Morens, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008954 · Cited by 216
Gao, X., Qi, L., Qiao, N., Choi, H. K., Curhan, G., Tucker, K. L., & Ascherio, A. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091041 · Cited by 186
Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation
Church, W. H., & Ward, V. L. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90285-2 · Cited by 173
Diet, Urate, and Parkinson's Disease Risk in Men
Gao, X., Chen, H., Choi, H. K., Curhan, G. C., Schwarzschild, M. A., & Ascherio, A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm385 · Cited by 151
Polidori, M. C., & Mecocci, P. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4608 · Cited by 148
Tončev, G., Miličić, B., Tončev, S., & Samardžić, G. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00384.x · Cited by 137
The role of uric acid in protection against peroxynitrite-mediated pathology
Scott, G. S., & Hooper, D. C. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1118 · Cited by 89
Plasma Urate and Progression of Mild Cognitive Impairment
Irizarry, M. C., Raman, R., Schwarzschild, M. A., Becerra, L. M., Thomas, R. G., Peterson, R. C., Ascherio, A., & Aisen, P. S. S. (2008) · Neurodegenerative Diseases · doi:10.1159/000170883 · Cited by 86
The Clinical Dementia Rating scale
Dooneief, G., Marder, K. S., Tang, M., & Stern, Y. (1996) · Neurology · doi:10.1212/wnl.46.6.1746 · Cited by 86
Tohgi, H., Abe, T., Takahashi, S., & Kikuchi, T. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02261005 · Cited by 69
Brain and brawn: Parallels in oxidative strength
Moreira, P. I., Honda, K., Zhu, X., Nunomura, A., Casadesús, G., Smith, M. A., & Perry, G. L. (2006) · Neurology · doi:10.1212/01.wnl.0000192307.15103.83 · Cited by 56
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins
Spitsin, S. V., Hooper, D. C., Mikheeva, T., et al. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700305 · Cited by 47
Waugh, W. H. (2008) · Gerontology · doi:10.1159/000122618 · Cited by 35
Cited by
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Endogenous non-enzymatic antioxidants in the human body
Mirończuk-Chodakowska, I., Witkowska, A. M., & Zujko, M. E. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.005 · Cited by 613
RONS and Oxidative Stress: An Overview of Basic Concepts
Aranda-Rivera, A. K., Cruz-Gregorio, A., Arancibia-Hernández, Y. L., Hernández-Cruz, E. Y., & Pedraza-Chaverri, J. (2022) · Oxygen · doi:10.3390/oxygen2040030 · Cited by 384
Xu, H., Li, R., Wang, L., Wang, T., Luo, Y., Wei, Y., & Chen, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.017 · Cited by 9
Metadata
- Authors
- Bowman, G. L., Shannon, J., Frei, B., Kaye, J. A., & Quinn, J. F.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-03-11
- Volume
- 19
- Issue
- 4
- Pages
- 1331-1336
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1952539308
- Cited by
- 258
- References
- 36
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.